This inventor holds 1 USPTO granted patent. Top assignee: Geneseeq Technology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Shiting Tang: Innovator in Multi-Cancer Early Detection
Introduction
Shiting Tang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of cancer detection through his innovative research and development. His work focuses on the application of gene markers for early detection of multiple cancers, which has the potential to revolutionize cancer diagnostics.
Latest Patents
Shiting Tang holds a patent for the "Application of gene markers in multi-cancer early detection, method for constructing early detection model, and detection device." This patent involves conducting low-coverage whole-genome sequencing on cell-free DNAs (cfDNAs) from plasma samples. The process analyzes six differential features of cfDNA fragments for each type of cancer. By utilizing advanced modeling techniques, including convolutional neural networks and generalized linear models, Tang's invention enables the early detection of various cancers at a low sequencing depth.
Career Highlights
Shiting Tang is associated with Geneseeq Technology Inc., where he continues to advance his research in cancer detection technologies. His innovative approach combines cutting-edge genomic analysis with machine learning techniques, showcasing his commitment to improving healthcare outcomes.
Collaborations
Shiting Tang collaborates with notable colleagues, including Shuyu Wu and Xue Wu. Their combined expertise enhances the research and development efforts at Geneseeq Technology Inc., fostering an environment of innovation and discovery.
Conclusion
Shiting Tang's contributions to multi-cancer early detection highlight the importance of innovation in medical technology. His work not only advances scientific understanding but also has the potential to save lives through earlier diagnosis and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile